Michael McShea, RPH

Pharmacists must be experts on follow-on biologics (FOBs), including biosimilars, so they can provide education to health professionals about safe prescribing and use, which ultimately affects patient care.

Pharmacists need to be experts on follow-on biologics, including biosimilars, so they can provide education to health professionals about safe prescribing and use.

Health care practitioners need to prepare for myriad questions regarding biosimilars and follow-on biologic drugs as they enter the market.